Health CarePharmaceuticals & Biotechnology
  • Price (USD)94.47
  • Today's Change-0.21 / -0.22%
  • Shares traded2.56m
  • 1 Year change60.31%
  • Beta1.5209
Data delayed at least 15 minutes, as of Nov 22 2017 21:01 GMT.
More ▼

Key statistics

On Wednesday, AbbVie Inc (ABBV:NYQ) closed at 94.47, -3.86% below its 52-week high of 98.26, set on Oct 20, 2017.
52-week range
58.60Nov 23 201698.26Oct 20 2017
Markit short selling activity
Previous close94.68
Average volume4.60m
Shares outstanding1.59bn
Free float1.59bn
P/E (TTM)22.83
Market cap150.59bn USD
EPS (TTM)4.14
Annual div (ADY)2.84
Annual div yield (ADY)3.00%
Div ex-dateOct 12 2017
Div pay-dateNov 15 2017
Next div ex-dateJan 11 2018
Next div pay-dateFeb 15 2018
Data delayed at least 15 minutes, as of Nov 22 2017 21:01 GMT.
More ▼

Investors Chronicle View

The last IC recommendation on AbbVie Inc shares was Hold at 4,801.00 on 16 Jul 2014Read the full article
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.